Clinical trials: Ischaemic Type Biliary Lesion
Ischaemic Type Biliary Lesion
Ischemic Preconditioning in Major Hepatectomy
To evaluate the accuracy of ischemic preconditioning (IPC) as a protective maneuver against ischemia/reperfusion lesion in patients undergoing major liver resection with intermittent portal triad Clamping (IPTC).
- Trial name
- HECLA (NCT00908245)
- Testing
- Control, Preconditioning ischemia
- Where
- France
- Volunteers
- 81 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Ischemic-type Biliary Lesions
Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions
Ischemic-type biliary lesions (ITBLs) are a major cause of graft loss and mortality after orthotopic liver transplantation (OLT). For now, there are still lacking effective treatment for ITBLs.
- Trial name
- NCT02223897
- Testing
- huc-MSCs
- Where
- China
- Volunteers
- 66 people
- Sponsor
- Yang Yang